Work

Phase II study of immunomodulation with granulocyte-macrophage colony-stimulating factor, interleukin-2, and rituximab following autologous stem cell transplant in patients with relapsed or refractory lymphomas

Year: 2010

Type: article

Study design: Clinical Trial

Source: Leukemia & lymphoma/Leukemia and lymphoma

DOI: 10.3109/10428194.2010.486876

Authors: Xavier Poiré, Justin Kline, David Grinblatt, Todd Zimmerman, Kathy Conner, Carolyn Muhs, Thomas Gajewski, Koen Van Besien, Sonali M. Smith

Institutions: University of Chicago Medical Center, University of Chicago, University of Chicago Medicine Comprehensive Cancer Center, Endeavor Health

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: G3333771039, Homeostatic proliferation and regulatory T cell depletion as cancer immunotherapy

OpenAlex ID: W2037329643

FWCI: 1.537

Cites: 56

Cited by: 15

Related to: 10